Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-6 of 6
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
22-Dec-2014LARP1 post-transcriptionally regulates mTOR and contributes to cancer progressionMura, M; Hopkins, TG; Michael, T; Abd-Latip, N; Weir, J, et al
20-May-2015Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignanciesBlagden, SP; Rizzuto, I; Stavraka, C; O'Shea, D; Suppiah, P, et al
20-May-2015A first in human Phase I/II study of NUC-1031 in patients with advanced gynecological cancersBlagden, SP; Rizzuto, I; Stavraka, C; O'Shea, D; Suppiah, P, et al
1-Mar-2015Risk of Ovarian Cancer Relapse Score A Prognostic Algorithm to Predict Relapse Following Treatment for Advanced Ovarian CancerRizzuto, I; Stavraka, C; Chatterjee, J; Borley, J; Hopkins, TG, et al
2-Oct-2018Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I studyBlagden, SP; Rizzuto, I; Suppiah, P; O'Shea, D; Patel, M, et al
1-Sep-2010The RNA binding protein Larp1 regulates cell division, apoptosis and cell migrationBurrows, C; Latip, NA; Lam, S-J; Carpenter, L; Sawicka, K, et al